Enhanced anti-tumor effects of HPV16E749–57-based vaccine by combined immunization with poly(I:C) and oxygen-regulated protein 150

Immunol. Cell Biol.

Melinda Fitzgerald, Ian P. Hayward, Anita C. Thomas et al. · 1995 · 2.6K citations

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

K Y Lin, Frank Guarnieri, Kevin F. Staveley-O’Carroll et al. · PubMed · 1996 · 1K citations

Medicine, Immunology, Oncology +17

Toll-like receptor 3 promotes cross-priming to virus-infected cells

Oliver Schulz, Sandra S. Diebold, Margaret Chen et al. · Nature · 2005 · 902 citations

Life Sciences, Immunology, Molecular Biology +14

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

M. Paula Longhi, Christine Trumpfheller, Juliana Idoyaga et al. · The Journal of Experimental Medicine · 2009 · 646 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Maaike E. Ressing, Alessandro Sette, Remco M.P. Brandt et al. · The Journal of Immunology · 1995 · 386 citations

Life Sciences, Immunology, Oncology +17